Breaking News: The FDA Advisory Board unanimously recommends booster doses of Moderna’s COVID-19 vaccine to people over the age of 65 who are at high risk for an underlying illness or work.
- The FDA’s advisory board voted to recommend approval of Covid booster shots of Moderna’s vaccine.
- Booster shots are only approved for people over the age of 65 who are at high risk for work
Boosters are only approved for older people over the age of 65 and those at high risk of developing severe cases of the virus due to underlying illness.
Almost exactly one month after the Vaccine and Related Biopharmaceutical Advisory Board (VRBPAC) approved the booster immunization of the Pfizer-BioNTech vaccine.
The FDA’s advisory board voted to recommend approval of Covid booster shots of Moderna’s vaccine.Photo: Healthcare workers holding a Vial of Moderna COVID-19 vaccine in New York City, January 2021
In August, the COVID-19 Vaccine Booster Shot will be rolled out for all Americans from September 20th at the White House.
At that time, the Biden administration published a study citing the ability of delta mutants to cause weakened immunity and breakthrough infections.
However, FDA and US Centers for Disease Control and Prevention (CDC) officials objected, saying there was not enough evidence that the vaccine was less effective.
As a result, Pfizer’s vaccine boosters will not be deployed until September 22 (after the target deployment date) and will only be deployed to specific groups, such as Moderna.
Second, Moderna booster shots need to be approved by the FDA and approved by the US Centers for Disease Control and Prevention (CDC) Advisory Board.
This is the latest news and will be updated.
FDA Advisory Board recommends booster vaccination with Moderna’s COVID-19 vaccine
Source link FDA Advisory Board recommends booster vaccination with Moderna’s COVID-19 vaccine